Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001181431-12-002269)

Filing Details

Accession Number:: 0001181431-12-002269
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2012-01-11 17:41:41
Reporting Period:: 2012-01-09

Filing Date:: 2012-01-11
Accepted Time:: 2012-01-11 17:41:41
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1070336	Achillion Pharmaceuticals Inc	ACHN	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1378589	Kay Mary Fenton	C/O Achillion Pharmaceuticals 300 George Street New Haven CT 06511	Svp And Cfo	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2012-01-09	4,375	$9.34	0	No	4	S	Direct
Common Stock	Acquisiton	2012-01-10	10,625	$1.60	10,625	No	4	M	Direct
Common Stock	Disposition	2012-01-10	10,625	$12.00	0	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Employee Stock Option (Right to Buy)	Disposition	2012-01-10	10,625	$0.00	10,625	$1.60

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2014-12-16	No	4	M	Direct

Footnotes

This option was granted on December 16, 2004 and vested over a four year period with 25% of the shares vesting on the first anniversary of the date of grant and an additional 6.25% vesting at the end of each three-month period thereafter.